William Blair Upgrades Idenix Pharmaceuticals (IDIX) to Outperform
Tweet
Share
E-mailGet Alerts IDIX Hot Sheet
Price: $24.50 --0%
Rating Summary:
1 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 5
Rating Summary:
1 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 5
Join SI Premium – FREE
William Blair upgraded Idenix Pharmaceuticals (NASDAQ: IDIX) from Market Perform to Outperform.
For an analyst ratings summary and ratings history on Idenix Pharmaceuticals click here. For more ratings news on Idenix Pharmaceuticals click here.
Shares of Idenix Pharmaceuticals closed at $7.10 yesterday.
For an analyst ratings summary and ratings history on Idenix Pharmaceuticals click here. For more ratings news on Idenix Pharmaceuticals click here.
Shares of Idenix Pharmaceuticals closed at $7.10 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GLJ Research Upgrades Cleveland-Cliffs (CLF) to Buy
- Jefferies Upgrades SRF Ltd (SRF:IN) to Hold
- Macquarie Upgrades United Spirits Ltd. (UNITDSPR:IN) to Outperform
Create E-mail Alert Related Categories
UpgradesRelated Entities
William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
